Skip to main content
OpenTrials
Completed

NCT Number: NCT04451005

Diagnostic Evaluation of Sarcopenia in Elderly Patients

Sarcopenia is a generalized progressive skeletal muscle disorder that represents a related physiological vulnerability that is associated with or increases the likelihood of adverse outcomes, including falls, fractures, physical disability and death. The parameters used to assess sarcopenia in clinical practice have limited use due to their custody.

In this perspective, this study proposes or develops a tool for the diagnosis of having sarcopenia with a specific boa and a sensitive boa.

low cost and useful.

Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected

This study was of clinical importance, due to sarcopenia and a relevant factor, and could lead to consequences and poor prognosis in patients with gold, and it was not a method of clinical practice to properly endorse body composition in this population.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Sarcopenia is a progressive and generalized skeletal muscle disorder that represents an age-related physiological vulnerability that is associated with an increased likelihood of adverse outcomes, including falls, fractures, physical disability and mortality. The parameters used to assess sarcopenia in clinical practice have limited use due to its cost.

In this perspective, this study proposes the development of a tool for the diagnosis of having sarcopenia with good specificity and good sensitivity and of low cost and useful.

Elderly patients (n = 403) from the Geriatrics Outpatient Clinic of Hospital das Clínicas, Faculty of Medicine, University of São Paulo will be selected. After signing the informed consent, sarcopenia will be assessed using the reference method (DXA) and anthropometry. The data obtained by the methods are treated statistically to obtain correlation and thus a new tool for the evaluation of sarcopenia patients in the elderly can be developed.

This study is of clinical importance, as sarcopenia is a relevant factor and can lead to consequences and poor prognosis in elderly patients, and there is no low-cost method in clinical practice to properly assess body composition in this population.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 60 years
  • Sign free and informed consent;
  • Demonstrate interest, conditions and availability to participate in all procedures included in the study protocol;

Exclusion criteria

  • Refusal to participate;
  • Patients who have not undergone cognitive testing;
  • Physical amputation;
  • Patients undergoing interventional treatment for sarcopenia;

Treatment and study plan

0

Other

Elderly patients with sarcopenia

Primary outcomes

  1. Sarcopenia in the elderly

    Time frame: 12 months

    Evaluation of sarcopenia in the elderly

Secondary outcomes

  1. Development of a new tool for sarcopenia screening

    Time frame: 12 months

    Development of a new tool for sarcopenia screening

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Registry information

Official study title

Development of a New Sarcopenia Screening Tool in the Elderly

Important dates

Study start
2016
Primary completion
2018
Study completion
2019
First posted
Jun 30, 2020
Registry last updated
Jun 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.